Litigation Support Services

Independent statistical expert-witness and consulting support for medical-device, pharmaceutical, and clinical-trial disputes — from early case assessment through expert reports and, where retained to do so, trial testimony. Dr. Li accepts engagements for both plaintiff and defense, each subject to a conflicts-of-interest check.

Two Engagement Tracks

Consulting and testifying roles

Counsel can retain Dr. Li in a non-testifying advisory capacity, as a disclosed testifying expert, or move from one to the other as a matter develops.

Track 1 — Consulting

Non-testifying advisory support

Behind-the-scenes statistical analysis and strategy to help counsel understand the numbers and shape the case.

  • Early case assessment and evaluation of statistical strengths and weaknesses
  • Methodology review of studies, analyses, and submissions at issue
  • Identifying flaws, assumptions, and limitations in an opposing party's analysis
  • FDA regulatory and evidence-strategy review, including 505(b)(2)-pathway considerations
Track 2 — Testifying

Disclosed testifying expert

Independent opinions documented and defended on the record. Dr. Li is available for and welcomes testifying engagements.

  • Expert reports under the applicable rules of procedure
  • Declarations and affidavits
  • Rebuttal of opposing statistical experts
  • Daubert and admissibility support
  • Deposition and trial testimony
Scope of Work

What Dr. Li can do

Drawing on regulatory review experience at FDA/CDRH and biostatistics roles in cardiovascular devices and vaccine development, Dr. Li offers a focused set of statistical services for litigation.

Statistical methodology review

Independent assessment of study design, analysis methods, assumptions, and conclusions in the data at issue.

Adverse-event & incidence analysis

Evaluation of adverse-event and incidence rate calculations, denominators, and comparative methodology.

FDA regulatory & clearance opinion

Statistical perspective on PMA, De Novo, 510(k), IDE, and real-world-evidence considerations from a former CDRH reviewer.

Rebuttal reports

Critical response to opposing statistical experts, identifying methodological errors and overstated conclusions.

Daubert & admissibility support

Analysis supporting or challenging the reliability and fit of statistical evidence and expert methodology.

Expert reports, declarations & affidavits

Written opinions prepared to the standards applicable to the forum and stage of the matter.

Deposition & trial testimony

Available to present and defend statistical opinions at deposition and at trial when retained to testify.

Early case assessment

Threshold review of the statistical issues so counsel can gauge exposure and direction before committing resources.

Pharmaceutical evidence & regulatory strategy review

Assessment of evidence-generation strategy, clinical and biomarker evidence gaps, and FDA pathway considerations.

Plain-language explanation & demonstratives

Clear, accurate translation of statistical concepts for judges and juries, including supporting demonstratives.

Availability & Independence

How Dr. Li approaches an engagement

Dr. Li accepts engagements from both plaintiff and defense. Every prospective engagement begins with a conflicts-of-interest check before any work is undertaken. His opinions are independent and methodology-driven: they follow the data and the applicable statistical standards rather than the position of the retaining party.

Prior experience does not predict or guarantee any particular outcome. Each matter is assessed on its own facts, data, and record.

Getting Started

How an engagement starts

  • Initial confidential discussion of the matter and the statistical questions involved
  • Conflicts-of-interest check
  • Written engagement agreement defining scope, role, and terms
  • Analysis and deliverables begin once the engagement is confirmed

No duty of confidentiality arises until an engagement is confirmed in writing. Please do not send privileged or confidential information before the engagement is in place.

Discuss a matter with Dr. Li

Tell us about the statistical issues in your case. Initial discussions are confidential, and every engagement is subject to a conflicts-of-interest check.